Astra Nova Training and ACRES announced a Strategic Alliance collaboration.
Astra Nova Training, a global provider of innovative and comprehensive consultancy and pharma training services, and the Alliance for Clinical Research Excellence and Safety (ACRES), a non-profit integrating the expertise and investments of research stakeholders world-wide to build and maintain a global system for clinical trials, are pleased to announce a Strategic Alliance collaboration to improve the expertise of industry professionals through improved and easily available training quality, thus enhancing greater patient safety.
Since its establishment in 2008, UK-based Astra Nova has introduced an international network of over 140 industry experts, based in over 50 countries around the globe. In addition, the company has launched over 20 free and commercial online training courses, accessible on their Learning Management System. More than 5,000 professionals worldwide have obtained industry certification through their in-house and online training solutions.
ACRES, a non-profit organization operating in the public interest, is dedicated to enhancing quality, safety, integrity and operational effectiveness in drug development and health research through the building of a global system for clinical research. To achieve this, ACRES has adopted an Alliance-based model whereby those organizations with a stake in clinical trials being conducted according to the highest standards of safety, quality and efficiency, are the very organizations that—together—build the comprehensive, integrated system to make such excellence possible.
Astra Nova, with its strong commitment to corporate social responsibility (CSR), will make available interactive and easy-to access online training solutions for ACRES Global Platform of services. This CSR commitment, mirrored by ACRES, is exemplified in Astra Nova’s Better Industry Initiative (Bii), which provides free and commercial high-quality training courses and other resources with an ultimate goal of better serving patients by equipping future and current industry professionals with more refined skills and workflow efficiency tools.
With Astra Nova, ACRES will provide timely information on critical training topics and materials needed globally and they will partner on Learning Management Systems development. Other collaborative efforts involve jointly organizing multi-stakeholder events dedicated to improving the conduct of clinical research globally.
Astra Nova’s Business Development Director, Ms. Maya Zlatanova said: “Our main goal is to improve patient safety and allow easier access to industry regulations, standards and knowledge. We believe that everyone will benefit from this partnership and the results of this collaboration will become visible in the very first days of establishing it.”
Dr Matthew Whalen, COO of ACRES, noted “ACRES work is conducted through alliances and Astra Nova brings added depth to ACRES network of organizations committed to transforming the world of clinical research”. Whalen added, “We are looking forward to working together with Astra Nova in a variety of ways to realize our shared collaboration goal of providing more innovative solutions, broader standardization, better quality of service, greater safety and increased efficiency.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.